# Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease

> **NCT05986318** · PHASE2 · RECRUITING · sponsor: **David Palma** · enrollment: 98 (estimated)

## Conditions studied

- Lung Cancer
- Interstitial Lung Disease

## Interventions

- **DIETARY_SUPPLEMENT:** N-Acetyl cysteine
- **DRUG:** Dexamethasone Oral
- **DIETARY_SUPPLEMENT:** N-Acetyl cysteine Placebo
- **DRUG:** Dexamethasone Placebo
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT05986318
- **Lead sponsor:** David Palma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-07
- **Primary completion:** 2028-07-01
- **Final completion:** 2032-12-31
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05986318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05986318, "Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05986318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*